Predicting cancer return after penis-sparing surgery for penile cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how often penile cancer comes back after low-risk, penis-sparing surgery and how that affects long-term health. It may help doctors understand which patients need closer follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a low-risk, penis-sparing surgery for penile squamous cell carcinoma, such as wide local excision, partial glansectomy, laser ablation, circumcision, or glans resurfacing.
- You did not have a partial or total penectomy as your first surgery.
- You did not have cancer spread to lymph nodes in the groin at the time of diagnosis.
- You did not have cancer spread to other parts of the body (distant metastases) at diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a penile rehabilitation program for men who have nerve-sparing prostate cancer surgery. It aims to help improve erections and sexual function after the procedure.
This study looks at how people should be followed after treatment for testicular cancer (surgery and, for some, chemotherapy). It may help improve follow-up plans while keeping an eye out for cancer coming back.
This trial tests a new approach to groin lymph node surgery in men with penile cancer. It aims to reduce side effects while still being effective.
This study looks at factors that can predict whether prostate cancer will come back in the 10 years after robot-assisted prostate removal surgery, and how well bladder control (urinary continence) recovers. It helps doctors understand which patients might do better long-term.
This study tests a new way to predict if non-small cell lung cancer will return after surgery. You will give blood samples to look for cancer cells, and the team will build a model to help plan better follow-up care.
This study looks at factors that may predict whether prostate cancer comes back after robot-assisted removal of the prostate. Researchers will review medical records of patients who had this surgery to find patterns that help doctors predict recurrence.
Hear when a new Penile Cancer, Recurrent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.